The Global Veterinary Artificial Insemination market is anticipated to reach USD 5.94 billion by 2027, according to a new report by Reports and Data. The Artificial Insemination Market (AI) is expected to see a rise in demand due to increased animal protein consumption and increased demand for high cattle productivity milk yields. Market players are introducing artificial insemination to meet the ever-increasing demand to breed high-quality livestock and increase efficiency. Demand has increased over the years, owing to the growing prevalence of various animal diseases, such as zoonotic diseases, and the increasing adoption of animals that follow them.
According to the 2019 publication of the Food and Agriculture Organization (FAO), livestock accounted for approximately 40 % of the global value of agricultural production in developed countries and 20% in developing countries, providing food security and livelihood for more than 1.3 billion people worldwide. Favorable government regulations aimed at increasing productivity often contribute to growth; for example, in 2018 the Indian government authorized an Agriculture Export Policy to boost the nation's agricultural economic growth. The new strategy aims to raise India's agricultural production to USD 60 billion by 2022 and USD 100 billion in the next few years with a stable foreign-policy system.
The industry meets the guidelines set by the International Artificial Insemination Society (ISAG) and leading laboratories for animal science, such as Davis University of California (U.C. Davis). The standard ISAG panel consists of 18 STR markers, and every artificial insemination business needs to adopt the panel and norm set by the authority. Nevertheless, increasing populations are expected to pose a continuous challenge to food supply and animal protein requirement, boosting demand development.
Leading companies operating in the market and profiled in the report include:
Select Sires, Inc., Swine Genetics International, SEMEX, Zoetis, Cooperative Resource International (GENEX), Cogent, Viking Genetics, Genus plc, Polar Genetics India, and Fox Fire Farm, among others.
The pharmaceutical and healthcare sector is rapidly expanding in terms of revenue in the recent years and is expected to register robust CAGR over the forecast period of 2028. Factors such as rapid advancements in the pharma and healthcare sector, adoption of latest technologies, tools and equipment, emergence of various new diseases and improvements in healthcare facilities and infrastructure. In addition, rising healthcare expenditure, increasing per capita income in the developing countries and favorable reimbursement policies are fueling market growth. Increasing funds by various public and private sectors and increasing investments to develop enhanced products and devices are also boosting market growth. Moreover, increasing preference for ambulatory services and point of care services, and increasing funds for research centers and hospitals for drug discovery is expected to fuel market growth going ahead.
The report provides details about competitive landscape of global Veterinary Artificial Insemination market focusing on every market player, its global position, revenue generation product portfolio, company overview, financial planning and business expansion plans. The global Veterinary Artificial Insemination market is quite competitive and comprises various key players at global and regional levels. Key players are investing in research and development activities, and strategizing various plans such as mergers and acquisitions, partnerships, joint ventures, new product launches, to enhance their product base and strengthen their market position.
Veterinary Artificial Insemination Market Segmentation:
Product Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
- Normal Semen
- Sexed Semen
Animal Type Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
End-Use Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
- Veterinary Hospitals
- Animal Husbandry
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of APAC)
- Latin America (Brazil, Rest of LATAM)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3476
Thank you for reading the research report. We also provide report customization as per client request. Kindly contact us to know more about this customization feature and our team will offer you with the best suited report.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.